Literature DB >> 2965153

Inhaled ethylene oxide induces preneoplastic foci in rat liver.

B Denk1, J G Filser, D Oesterle, E Deml, H Greim.   

Abstract

The metabolite of E, EO, has been shown to be an extrahepatic carcinogen in rats in long-term studies. By means of a rat liver foci bioassay with 3 to 4 days old Sprague-Dawley rats, EO showed an initiating capacity in the livers of female, but not of male rats, measured as incidence of foci deficient in ATPase. After inhalation of 55 and 100 ppm EO, 8 h daily, 5 days weekly, and over 3 weeks, 1 week of pause, and another 8 weeks of promotion with polychlorinated biphenyls, foci incidence was generally low. But it was concentration dependently higher than in controls 12 weeks after starting the experiment. A linear concentration-effect relationship existed with a correlation coefficient of r = 0.991. With 33 ppm EO the number of foci was not enhanced significantly. The administration of 10,000 ppm E did not result in an enhanced foci incidence. In general the carcinogenic potential of EO, which has not been shown so far to cause hepatic tumors in rats, could be demonstrated in rat liver using a sensitive rat liver foci bioassay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965153     DOI: 10.1007/bf00390483

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  Kinetics and disposition in toxicology. Example: carcinogenic risk estimate for ethylene.

Authors:  H M Bolt; J G Filser
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

2.  Chronic toxicity and oncogenicity bioassay of inhaled ethylene in Fischer-344 rats.

Authors:  T E Hamm; D Guest; J G Dent
Journal:  Fundam Appl Toxicol       Date:  1984-06

3.  Exhalation of ethylene oxide by rats on exposure to ethylene.

Authors:  J G Filser; H M Bolt
Journal:  Mutat Res       Date:  1983-04       Impact factor: 2.433

4.  Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide.

Authors:  C J Calleman; L Ehrenberg; B Jansson; S Osterman-Golkar; D Segerbäck; K Svensson; C A Wachtmeister
Journal:  J Environ Pathol Toxicol       Date:  1978 Nov-Dec

5.  Pharmacokinetics of halogenated ethylenes in rats.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1979-06-08       Impact factor: 5.153

6.  Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats.

Authors:  D W Lynch; T R Lewis; W J Moorman; J R Burg; D H Groth; A Khan; L J Ackerman; B Y Cockrell
Journal:  Toxicol Appl Pharmacol       Date:  1984-10       Impact factor: 4.219

7.  Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin.

Authors:  S Osterman-Golkar; P B Farmer; D Segerbäck; E Bailey; C J Calleman; K Svensson; L Ehrenberg
Journal:  Teratog Carcinog Mutagen       Date:  1983

8.  Benzo[a]pyrene initiates enzyme-altered islands in the liver of adult rats following single pretreatment and promotion with polychlorinated biphenyls.

Authors:  E Deml; D Oesterle; F J Wiebel
Journal:  Cancer Lett       Date:  1983-07       Impact factor: 8.679

9.  Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats.

Authors:  H M Bolt; J G Filser; F Störmer
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

10.  Brain tumors in F344 rats associated with chronic inhalation exposure to ethylene oxide.

Authors:  R H Garman; W M Snellings; R R Maronpot
Journal:  Neurotoxicology       Date:  1985       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.